Kavita Chalasani

Kavita Chalasani, PhD, is a Research Scientist at NephroSant, Inc., a company based in Brisbane, California.2 Her work focuses on developing innovative urine-based tests for detecting kidney-related conditions, particularly in the field of renal transplantation.1

Professional Background

Dr. Chalasani has a strong background in biological sciences, with expertise in neuroscience and developmental biology. Her educational background includes:

• PhD: She studied the role of N-cadherin in regulating cell division and differentiation in the developing central nervous system.3
• Postdoctoral research: She was affiliated with the University of Maryland, where she contributed to several research works.4

Current Role and Research

At NephroSant, Dr. Chalasani is involved in groundbreaking research on non-invasive diagnostic methods for kidney-related issues:

1. She has contributed to the development of QSant (formerly known as QiSant), a novel urine-based test for detecting allograft rejection in renal transplant patients.5
2. This test generates a urinary Q-Score, which helps in the quantitative assessment of kidney injury.1

Publications and Contributions

Dr. Chalasani has been involved in multiple research publications:

• She has 5 research works with 61 citations to her name.4
• One of her significant contributions is the clinical and analytical validation study of the urine-based test for allograft rejection detection.5

Dr. Kavita Chalasani's work at NephroSant represents an important step forward in the field of nephrology, particularly in developing non-invasive diagnostic tools for kidney transplant patients. Her research aims to improve patient care and outcomes in the realm of renal health.